EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of altered dopaminergic modulation of prolactin luteinizing hormone and tsh secretion in patients with normo prolactinemic amenorrhea


Acta Endocrinologica 106(1): 8-14
Evidence of altered dopaminergic modulation of prolactin luteinizing hormone and tsh secretion in patients with normo prolactinemic amenorrhea
Basal plasma concentrations of Prl, [prolactin], LH [luteinizing hormone], FSH, growth hormone, TSH, T3, T4, [triiodothyronine, thyroxine] resin T3 uptake (RT3U), and estradiol as well as hormone responses to i.v. metoclopramide (MTC) were investigated in 16 consecutive patients with normoprolactinemic, normogonadotropic amenorrhea. The control group consisted of 17 normal menstruating women between day 3 and 6 of the menstrual cycle. The mean age of the amenorrheic patients was 24.0 yr (range 19-34) and the mean duration of amenorrhea was 31 mo. (range 12-60). Amenorrheic patients had significantly (P < 0.05) lower basal levels of LH, estradiol and RT3U, whereas other hormone levels were similar in the 2 groups. Plasma Prl and TSH concentrations rose significantly (P < 0.05) after the administration of MTC in the 2 groups. A significant positive correlation (r = 0.69 P < 0.01) was found between the TSH response to MTC and basal TSH levels in controls, but not in amenorrheic patients. Plasma LH levels increased significantly (P < 0.05) in amenorrheic patients, but not in controls. The Prl and TSH responses to MTC were significantly (P < 0.001) lower in amenorrheic patients than in normal women. In amenorrheic patients none of the hormonal parameters correlated significantly (P > 0.05) with the percentage of ideal body weight. The hormonal changes in amenorrheic patients may in part be caused by a raised dopaminergic activity leading to a depression of central ovulatory mechanisms.


Accession: 005411210



Related references

Evidence of altered dopaminergic modulation of prolactin luteinizing hormone fsh growth hormone and tsh secretion during chronic partial dopamine receptor blockade in normal women. Acta Endocrinologica 106(1): 1-7, 1984

Bromocriptine and estrogen modulation of gonadotropin release in normo prolactinemic and hyper prolactinemic patients with amenorrhea. Clinical Endocrinology 15(2): 125-132, 1981

Ovarian response to short term and long term administration of exogenous gonadotropin in patients with hyper prolactinemic amenorrhea comparison with women with normo prolactinemic amenorrhea. Fertility & Sterility 35(5): 590-591, 1981

Sulpiride a test for prolactin secretion in normo prolactinemic and hyper prolactinemic subjects. Spano, P F , Et Al (Ed ) Italian Brain Research Foundation Monograph Series: Sulpiride And Other Benzamides: Experimental And Clinical Pharmacology; International Workshop, Florence, Italy, Feb 17-18, 1978 Xiii+312p Italian Brain Research Foundation Press: Milan, Italy (Dist in The Usa By Raven Press: New York, N Y ) Illus : p175-184, 1979

Dopaminergic mechanisms and luteinizing hormone secretion 1. acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyper prolactinemic women. Journal of Clinical Endocrinology and Metabolism 50(1): 103-107, 1980

Patterns of spontaneous luteinizing hormone release in normo prolactinemic and hyper prolactinemic women. Acta Endocrinologica 97(3): 305-310, 1981

Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome. Hormone Research 35(1): 4-7, 1991

Evaluation of the estrogen-prolactin positive feedback and ovarian sensitivity to treatment with gonadotropins in normo- and hyper-prolactinemic amenorrhea patients (preliminary note). Archivio di Ostetricia E Ginecologia 85(3): 155-156, 1980

The control of gonadotropin release in women with hyper prolactinemic amenorrhea effect of estrogen and progesterone on the luteinizing hormone and follicle stimulating hormone response to luteinizing hormone releasing hormone. Clinical Endocrinology 5(5): 521-530, 1976

Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output. Biology of Reproduction 21(1): 141-148, 1979